Wednesday - April 24, 2024
Almeda Labs Assigned Patent for Amino Acid Formulations for Pancreatic Viability
Copyright © Targeted News Service, 2022
2022-01-24
ALEXANDRIA, Va., Jan. 24 -- Almeda Labs, Kansas City, Missouri, has been assigned a patent (No. 11,224,582, initially filed April 24, 2018) developed by two co-inventors for "amino acid formulations for pancreatic viability." The co-inventors are Stacy Tucker, Kansas City, Missouri, and Sushrutha Nagaraj, Kansas City, Missouri.

The full-text of the patent can be found at https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information or a free trial

Copyright Targeted News Service 2022